期刊文献+
共找到208篇文章
< 1 2 11 >
每页显示 20 50 100
ALKBH5 suppresses autophagic flux via N6-methyladenosine demethylation of ZKSCAN3 mRNA in acute pancreatitis
1
作者 Tao Zhang Shuai Zhu Geng-Wen Huang 《World Journal of Gastroenterology》 SCIE CAS 2024年第12期1764-1776,共13页
BACKGROUND Increasing evidence has demonstrated that N6-methyladenosine(m6A)RNA modification plays an essential role in a wide range of pathological conditions.Impaired autophagy is a critical hallmark of acute pancre... BACKGROUND Increasing evidence has demonstrated that N6-methyladenosine(m6A)RNA modification plays an essential role in a wide range of pathological conditions.Impaired autophagy is a critical hallmark of acute pancreatitis(AP).AIM To explore the role of the m6A modification of ZKSCAN3 in the regulation of autophagy in AP.METHODS The AP mouse cell model was established by cerulein-treated mouse pancreatic acinar cells(MPC-83),and the results were confirmed by the levels of amylase and inflammatory factors.Autophagy activity was evaluated by specific identification of the autophagy-related microstructure and the expression of autophagy-related genes.ZKSCAN3 and ALKBH5 were knocked down to study the function in AP.A m6A RNA binding protein immunoprecipitation assay was used to study how the m6A modification of ZKSCAN3 mRNA is regulated by ALKBH.RESULTS The increased expression of amylase and inflammatory factors in the supernatant and the accumulation of autophagic vacuoles verified that the AP mouse cell model was established.The downregulation of LAMP2 and upregulation of LC3-II/I and SQSTM1 demonstrated that autophagy was impaired in AP.The expression of ZKSCAN3 was upregulated in AP.Inhibition of ZKSCAN3 increased the expression of LAMP2 and decreased the expression of the inflammatory factors,LC3-II/I and SQSTM1.Furthermore,ALKBH5 was upregulated in AP.Knockdown of ALKBH5 downregulated ZKSCAN3 expression and restored decreased autophagic flux in AP.Notably,the bioinformatic analysis revealed 23 potential m6A modification sites on ZKSCAN3 mRNA.The m6A modification of ZKSCAN3 mRNA was significantly decreased in AP.Knockdown of ALKBH5 increased the modification of ZKSCAN3 mRNA,which confirmed that ALKBH5 upregulated ZKSCAN3 expression in a m6A-dependent manner.CONCLUSION ALKBH5 inhibits autophagic flux through m6A demethylation of ZKSCAN3 mRNA in AP,thereby aggravating the severity of the disease. 展开更多
关键词 Acute pancreatitis AUTOPHAGY ZKSCAN3 N6-methyladenosine ALKBH5
下载PDF
Advances of N6-methyladenosine modification on circular RNA in hepatocellular carcinoma
2
作者 CHU Feng-ran LIU Lu-zheng WU Jin-cai 《Journal of Hainan Medical University》 CAS 2024年第2期67-72,共6页
N6-methyladenosine(m6A)is a reversible epigenetic modification, which is one of the most abundant modifiers in eukaryotic cells and has been commonly reported in messenger RNAs and non-coding RNAs. The processing modi... N6-methyladenosine(m6A)is a reversible epigenetic modification, which is one of the most abundant modifiers in eukaryotic cells and has been commonly reported in messenger RNAs and non-coding RNAs. The processing modification of m6A regulates RNA transcription, processing, splicing, degradation, and translation, and plays an important role in the biological process of tumors. Circular RNA, which lacks the 5' cap structure, has been mistakenly regarded as a "junk sequence" generated by accidental shearing during the transcription process. However, it has been found that circRNAs can be involved in tumor invasion and metastasis through microRNAs, binding proteins, translated peptides, and m6A modifications. In this paper, we reviewed the role of m6A modifications in circRNA regulation and their functions in hepatocellular carcinoma and discussed their potential clinical applications and future development in this field. 展开更多
关键词 N6-methyladenosine Circular RNA MODIFICATION Hepatocellular carcinoma
下载PDF
N6-methyladenosine methylation regulates the tumor microenvironment of Epstein-Barr virus-associated gastric cancer
3
作者 Yu Zhang Fang Zhou +7 位作者 Ming-Yu Zhang Li-Na Feng Jia-Lun Guan Ruo-Nan Dong Yu-Jie Huang Su-Hong Xia Jia-Zhi Liao Kai Zhao 《World Journal of Gastrointestinal Oncology》 SCIE 2024年第6期2555-2570,共16页
BACKGROUND N6-methyladenosine(m6A)methylation modification exists in Epstein-Barr virus(EBV)primary infection,latency,and lytic reactivation.It also modifies EBV latent genes and lytic genes.EBV-associated gastric can... BACKGROUND N6-methyladenosine(m6A)methylation modification exists in Epstein-Barr virus(EBV)primary infection,latency,and lytic reactivation.It also modifies EBV latent genes and lytic genes.EBV-associated gastric cancer(EBVaGC)is a distinctive molecular subtype of GC.We hypothesized EBV and m6A methylation regulators interact with each other in EBVaGC to differentiate it from other types of GC.AIM To investigate the mechanisms of m6A methylation regulators in EBVaGC to determine the differentiating factors from other types of GC.METHODS First,The Cancer Gene Atlas and Gene Expression Omnibus databases were used to analyze the expression pattern of m6A methylation regulators between EBVaGC and EBV-negative GC(EBVnGC).Second,we identified Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)functional enrichment of m6A-related differentially expressed genes.We quantified the relative abundance of immune cells and inflammatory factors in the tumor microenvironment(TME).Finally,cell counting kit-8 cell proliferation test,transwell test,and flow cytometry were used to verify the effect of insulin-like growth factor binding protein 1(IGFBP1)in EBVaGC cell lines.RESULTS m6A methylation regulators were involved in the occurrence and development of EBVaGC.Compared with EBVnGC,the expression levels of m6A methylation regulators Wilms tumor 1-associated protein,RNA binding motif protein 15B,CBL proto-oncogene like 1,leucine rich pentatricopeptide repeat containing,heterogeneous nuclear ribonucleoprotein A2B1,IGFBP1,and insulin-like growth factor 2 binding protein 1 were significantly downregulated in EBVaGC(P<0.05).The overall survival rate of EBVaGC patients with a lower expression level of IGFBP1 was significantly higher(P=0.046).GO and KEGG functional enrichment analyses showed that the immunity pathways were significantly activated and rich in immune cell infiltration in EBVaGC.Compared with EBVnGC,the infiltration of activated CD4+T cells,activated CD8+T cells,monocytes,activated dendritic cells,and plasmacytoid dendritic cells were significantly upregulated in EBVaGC(P<0.001).In EBVaGC,the expression level of proinflammatory factors interleukin(IL)-17,IL-21,and interferon-γ and immunosuppressive factor IL-10 were significantly increased(P<0.05).In vitro experiments demonstrated that the expression level of IGFBP1 was significantly lower in an EBVaGC cell line(SNU719)than in an EBVnGC cell line(AGS)(P<0.05).IGFBP1 overexpression significantly attenuated proliferation and migration and promoted the apoptosis levels in SNU719.Interfering IGFBP1 significantly promoted proliferation and migration and attenuated the apoptosis levels in AGS.CONCLUSION m6A regulators could remodel the TME of EBVaGC,which is classified as an immune-inflamed phenotype and referred to as a“hot”tumor.Among these regulators,we demonstrated that IGFBP1 affected proliferation,migration,and apoptosis. 展开更多
关键词 N6-methyladenosine methylation Tumor microenvironment Epstein-Barr virus Gastric cancer Insulin-like growth factor binding protein 1
下载PDF
N^(6)-甲基腺苷修饰在动脉粥样硬化中的作用及药物干预的研究进展 被引量:1
4
作者 张晓璐 耿妙颖 +3 位作者 王雲 蒙胜勇 王一婧 姜希娟 《中国动脉硬化杂志》 CAS 2024年第4期277-284,共8页
N^(6)-甲基腺苷(m 6A)修饰是真核生物mRNA中最常见的表观转录组修饰形式之一,具有动态可逆性。该修饰过程由甲基转移酶、去甲基化酶和与m 6A结合的蛋白质协同作用,影响mRNA的代谢和功能。越来越多的研究表明,m 6A RNA修饰在动脉粥样硬化... N^(6)-甲基腺苷(m 6A)修饰是真核生物mRNA中最常见的表观转录组修饰形式之一,具有动态可逆性。该修饰过程由甲基转移酶、去甲基化酶和与m 6A结合的蛋白质协同作用,影响mRNA的代谢和功能。越来越多的研究表明,m 6A RNA修饰在动脉粥样硬化(As)等多种疾病的发生和发展中扮演重要角色。文章综述了m 6A RNA修饰与As的关系。全文对m 6A RNA修饰机制以及在As相关细胞(如内皮细胞、巨噬细胞和平滑肌细胞)中的作用进行了全面总结,并探讨了m 6A RNA修饰与As危险因素,如高脂饮食、缺血缺氧、振荡应力及高血压的关联。最后,文章还对药物干预m 6A RNA甲基化以实现延缓As的研究进行了综述,为探索As早期诊断和治疗的新靶点提供了重要参考。 展开更多
关键词 动脉粥样硬化 N^(6)-甲基腺苷修饰 甲基转移酶 去甲基化酶 药物干预
下载PDF
Recent progress in N6-methyladenosine modification in ocular surface diseases 被引量:1
5
作者 Wei Wang Jun Zou 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2023年第4期645-651,共7页
N6-methyladenosine(m6A)modification is a reversible process promoted by“writers”,inhibited by“erasers”,and processed by“readers”.During the last decade,increasing emphasis has been placed on the underlying roles... N6-methyladenosine(m6A)modification is a reversible process promoted by“writers”,inhibited by“erasers”,and processed by“readers”.During the last decade,increasing emphasis has been placed on the underlying roles of m6A modification owing to their great importance in biological significance.The abnormal regulation of m6A modification will lead to aberrant cellular behavior and various diseases.Recently,studies have demonstrated that m6A modification is closely associated with the genesis and progression of ocular surface diseases(OSDs).This review focus on the role of m6A modification and research progress in OSDs including fungal keratitis,herpes simplex keratitis,immunerelated keratoconjunctival diseases,pterygium,ocular chemical burns,and Graves’ophthalmopathy,which may provide new insights into and prospective applications for OSDs. 展开更多
关键词 N6-methyladenosine m6A modification EPIGENETICS ocular surface diseases
下载PDF
N^(6)-甲基腺苷修饰在肿瘤程序性细胞死亡中的作用
6
作者 谈元郡 王霞 +1 位作者 黄静(综述) 张百红(审校) 《中国肿瘤临床》 CAS CSCD 北大核心 2024年第2期86-93,共8页
非突变表观遗传重编程是肿瘤的关键特征之一,抵抗程序性细胞死亡是肿瘤的另一关键特征。作为体内最丰富的转录后表观遗传修饰方式,N^(6)-甲基腺苷(N^(6)-methyladenosine,m^(6)A)通过靶向调节程序性细胞死亡关键因子在肿瘤细胞凋亡、自... 非突变表观遗传重编程是肿瘤的关键特征之一,抵抗程序性细胞死亡是肿瘤的另一关键特征。作为体内最丰富的转录后表观遗传修饰方式,N^(6)-甲基腺苷(N^(6)-methyladenosine,m^(6)A)通过靶向调节程序性细胞死亡关键因子在肿瘤细胞凋亡、自噬、焦亡、铁死亡、坏死性凋亡、铜死亡中发挥重要作用。现已有靶向异常DNA甲基化、组蛋白修饰的表观遗传调节剂应用于临床,靶向m^(6)A修饰调控药物仍待探索。本文阐述了m^(6)A修饰调控肿瘤细胞程序性死亡的机制,旨在为通过调节m^(6)A修饰水平介导肿瘤细胞死亡这一潜在肿瘤治疗策略提供理论基础。 展开更多
关键词 N^(6)-甲基腺苷修饰 程序性细胞死亡 凋亡 自噬 焦亡 铁死亡 坏死性凋亡 铜死亡
下载PDF
Profiling of N6-methyladenosine methylation in porcine longissimus dorsi muscle and unravelling the hub gene ADIPOQ promotes adipogenesis in an m^(6)A-YTHDF1–dependent manner
7
作者 Huanfa Gong Tao Gong +2 位作者 Youhua Liu Yizhen Wang Xinxia Wang 《Journal of Animal Science and Biotechnology》 SCIE CAS CSCD 2023年第3期950-965,共16页
Background Intramuscular fat(IMF)content is a critical indicator of pork quality,and abnormal IMF is also relevant to human disease as well as aging.Although N6-methyladenosine(m^(6)A)RNA modification was recently fou... Background Intramuscular fat(IMF)content is a critical indicator of pork quality,and abnormal IMF is also relevant to human disease as well as aging.Although N6-methyladenosine(m^(6)A)RNA modification was recently found to regulate adipogenesis in porcine intramuscular fat,however,the underlying molecular mechanisms was still unclear.Results In this work,we collected 20 longissimus dorsi muscle samples with high(average 3.95%)or low IMF content(average 1.22%)from a unique heterogenous swine population for m^(6)A sequencing(m^(6)A-seq).We discovered 70genes show both differential RNA expression and m^(6)A modification from high and low IMF group,including ADIPOQ and SFRP1,two hub genes inferred through gene co-expression analysis.Particularly,we observed ADIPOQ,which contains three m^(6)A modification sites within 3’untranslated and protein coding region,could promote porcine intramuscular preadipocyte differentiation in an m^(6)A-dependent manner.Furthermore,we found the YT521-B homology domain family protein 1(YTHDF1)could target and promote ADIPOQ mRNA translation.Conclusions Our study provided a comprehensive profiling of m^(6)A methylation in porcine longissimus dorsi muscle and characterized the involvement of m^(6)A epigenetic modification in the regulation of ADIPOQ mRNA on IMF deposition through an m^(6)A-YTHDF1-dependent manner. 展开更多
关键词 ADIPOQ Intramuscular fat N6-methyladenosine PIG YTHDF1
下载PDF
Analysis of N6-methyladenosine-modified mRNAs in diabetic cataract
8
作者 Lei Cai Xiao-Yan Han +4 位作者 Dan Li Dong-Mei Ma Yu-Meng Shi Yi Lu Jin Yang 《World Journal of Diabetes》 SCIE 2023年第7期1077-1090,共14页
BACKGROUND Cataracts remain a prime reason for visual disturbance and blindness all over the world,despite the capacity for successful surgical replacement with artificial lenses.Diabetic cataract(DC),a metabolic comp... BACKGROUND Cataracts remain a prime reason for visual disturbance and blindness all over the world,despite the capacity for successful surgical replacement with artificial lenses.Diabetic cataract(DC),a metabolic complication,usually occurs at an earlier age and progresses faster than age-related cataracts.Evidence has linked N6-methyladenosine(m6A)to DC progression.However,there exists a lack of understanding regarding RNA m6A modifications and the role of m6A in DC pathogenesis.AIM To elucidate the role played by altered m6A and differentially expressed mRNAs(DEmRNAs)in DC.METHODS Anterior lens capsules were collected from the control subjects and patients with DC.M6A epitranscriptomic microarray was performed to investigate the altered m6A modifications and determine the DEmRNAs.Through Gene Ontology and pathway enrichment(Kyoto Encyclopedia of Genes and Genomes)analyses,the potential role played by dysregulated m6A modification was predicted.Real-time polymerase chain reaction was further carried out to identify the dysregulated expression of RNA methyltransferases,demethylases,and readers.RESULTS Increased m6A abundance levels were found in the total mRNA of DC samples.Bioinformatics analysis predicted that ferroptosis pathways could be associated with m6A-modified mRNAs.The levels of five methylation-related genes-RBM15,WTAP,ALKBH5,FTO,and YTHDF1-were upregulated in DC samples.Upregulation of RBM15 expression was verified in SRA01/04 cells with high-glucose medium and in samples from DC patients.CONCLUSION M6a mRNA modifications may be involved in DC progression via the ferroptosis pathway,rendering novel insights into therapeutic strategies for DC. 展开更多
关键词 N6-methyladenosine Diabetic cataract RNA Ferroptosis Epitranscriptomic microarray
下载PDF
N^(6)-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance 被引量:5
9
作者 Xian Lin Feng Wang +5 位作者 Jian Chen Jing Liu Yi-Bin Lin Li Li Chuan-Ben Chen Qin Xu 《Military Medical Research》 SCIE CAS CSCD 2022年第5期576-591,共16页
Background:Stemness and chemoresistance contribute to cervical cancer recurrence and metastasis.In the current study,we determined the relevant players and role of N^(6)-methyladenine(m^(6)A)RNA methylation in cervica... Background:Stemness and chemoresistance contribute to cervical cancer recurrence and metastasis.In the current study,we determined the relevant players and role of N^(6)-methyladenine(m^(6)A)RNA methylation in cervical cancer progression.Methods:The roles of m^(6)A RNA methylation and centromere protein K(CENPK)in cervical cancer were analyzed using bioinformatics analysis.Methylated RNA immunoprecipitation was adopted to detect m^(6)A modification of CENPK mRNA.Human cervical cancer clinical samples,cell lines,and xenografts were used for analyzing gene expression and function.Immunofluorescence staining and the tumorsphere formation,clonogenic,MTT,and EdU assays were performed to determine cell stemness,chemoresistance,migration,invasion,and proliferation in HeLa and SiHa cells,respectively.Western blot analysis,co-immunoprecipitation,chromatin immunoprecipitation,and luciferase reporter,cycloheximide chase,and cell fractionation assays were performed to elucidate the underlying mechanism.Results:Bioinformatics analysis of public cancer datasets revealed firm links between m^(6)A modification patterns and cervical cancer prognosis,especially through ZC3H13-mediated m^(6)A modification of CENPK mRNA.CENPK expression was elevated in cervical cancer,associated with cancer recurrence,and independently predicts poor patient prognosis[hazard ratio=1.413,95%confidence interval=1.078−1.853,P=0.012].Silencing of CENPK prolonged the overall survival time of cervical cancer-bearing mice and improved the response of cervical cancer tumors to chemotherapy in vivo(P<0.001).We also showed that CENPK was directly bound to SOX6 and disrupted the interactions of CENPK withβ-catenin,which promotedβ-catenin expression and nuclear translocation,facilitated p53 ubiquitination,and led to activation of Wnt/β-catenin signaling,but suppression of the p53 pathway.This dysregulation ultimately enhanced the tumorigenic pathways required for cell stemness,DNA damage repair pathways necessary for cisplatin/carboplatin resistance,epithelial-mesenchymal transition involved in metastasis,and DNA replication that drove tumor cell proliferation.Conclusions:CENPK was shown to have an oncogenic role in cervical cancer and can thus serve as a prognostic indicator and novel target for cervical cancer treatment. 展开更多
关键词 N^(6)-methyladenosine Centromere protein K Cervical cancer STEMNESS CHEMORESISTANCE
下载PDF
N^(6)-methyladenosine(m^(6)A)RNA modification in tumor immunity
10
作者 Siyi Zheng Hui Han Shuibin Lin 《Cancer Biology & Medicine》 SCIE CAS CSCD 2022年第4期385-397,共13页
Growing evidence supports that cancer progression is closely associated with the tumor microenvironment and immune evasion.Importantly,recent studies have revealed the crucial roles of epigenetic regulators in shaping... Growing evidence supports that cancer progression is closely associated with the tumor microenvironment and immune evasion.Importantly,recent studies have revealed the crucial roles of epigenetic regulators in shaping the tumor microenvironment and restoring immune recognition.N^(6)-methyladenosine(m^(6)A)modification,the most prevalent epigenetic modification of mammalian mRNAs,has essential functions in regulating the processing and metabolism of its targeted RNAs,and therefore affects various biological processes including tumorigenesis and progression.Recent studies have demonstrated the critical functions and molecular mechanisms underlying abnormal m^(6)A modification in the regulation of tumor immunity.In this review,we summarize recent research progress in the potential roles of m^(6)A modification in tumor immunoregulation,with a special focus on the anti-tumor processes of immune cells and involvement in immune-associated molecules and pathways.Furthermore,we review current knowledge regarding the close correlation between m6A-related risk signatures and the tumor immune microenvironment landscape,and we discuss the prognostic value and therapeutic efficacy of m^(6)A regulators in a variety of cancer types. 展开更多
关键词 N^(6)-methyladenosine(m^(6)A)modification immune evasion tumor microenvironment(TME) tumor immunology immune cells
下载PDF
蝉花中N^(6)-(2-羟乙基)-腺苷提取工艺优化及结构鉴定
11
作者 艾仁丽 谭艾娟 吕世明 《食用菌学报》 CSCD 北大核心 2023年第2期65-74,共10页
在单因素实验基础上,采用响应面法考察液料比、水浴温度、水浴时间对提取物中N6-(2-羟乙基)-腺苷[N^(6)-(2-hydroxyethyl) adenosine,HEA]含量的影响,优化出HEA的最佳提取工艺:以超纯水为溶剂、液料比118∶1、超声时间25 min、水浴温度2... 在单因素实验基础上,采用响应面法考察液料比、水浴温度、水浴时间对提取物中N6-(2-羟乙基)-腺苷[N^(6)-(2-hydroxyethyl) adenosine,HEA]含量的影响,优化出HEA的最佳提取工艺:以超纯水为溶剂、液料比118∶1、超声时间25 min、水浴温度24℃、水浴时间3.8 h,获得提取物中HEA含量为(0.836±0.030) mg·g^(-1)。采用大孔树脂、酸性氧化铝层析柱和半制备高效液相色谱仪(semi preparative high performance liquid chromatography,SP-HPLC)分离纯化提取液中HEA,采用核磁共振及电喷雾电离质谱(electrospray ionization mass spectrometry,ESI-MS)和核磁共振氢谱(proton nuclear magnetic resonance spectroscopy,^(1)H NMR)鉴定分离出的物质为HEA,经高效液相色谱(high performance liquid chromatography,HPLC)分析其纯度为99.32%。 展开更多
关键词 N^(6)-(2-羟乙基)-腺苷(HEA) 高效液相色谱法(HPLC) 响应面法(RSM) 结构鉴定
下载PDF
RNA m^(6)A甲基化修饰在脏器纤维化中的研究进展
12
作者 孙梓越 钱力 +1 位作者 李丹 刘学军 《医学综述》 CAS 2024年第4期406-411,共6页
脏器纤维化是器官慢性炎症过程中常见的病理改变,主要特征为细胞外基质过度沉积引起组织损伤,形成永久性瘢痕,导致器官功能障碍,目前该类疾病治疗手段有限,预后较差。表观遗传学参与了纤维化进程,其中RNA N^(6)-甲基腺苷(m^(6)A)甲基化... 脏器纤维化是器官慢性炎症过程中常见的病理改变,主要特征为细胞外基质过度沉积引起组织损伤,形成永久性瘢痕,导致器官功能障碍,目前该类疾病治疗手段有限,预后较差。表观遗传学参与了纤维化进程,其中RNA N^(6)-甲基腺苷(m^(6)A)甲基化修饰作为真核生物中最常见的RNA转录后修饰通过参与信使RNA核输出、剪接、翻译和稳定等调控基因表达,从而影响生物学功能。m^(6)A甲基化修饰通过关键修饰酶调控相关通路参与脏器纤维化的形成和发展,这为脏器纤维化的治疗提供了新方向。 展开更多
关键词 纤维化 N^(6)-甲基腺苷甲基化 表观遗传修饰
下载PDF
Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer 被引量:6
13
作者 Zhixian Liang Reilly LKidwell +1 位作者 Haijing Deng Qi Xie 《Cancer Biology & Medicine》 SCIE CAS CSCD 2020年第1期9-19,共11页
The biological roles of N6 methylation of nucleic acids have been extensively studied.Adenine methylation of RNA is the most prevalent RNA modification and has widespread effects on RNA splicing,translation,localizati... The biological roles of N6 methylation of nucleic acids have been extensively studied.Adenine methylation of RNA is the most prevalent RNA modification and has widespread effects on RNA splicing,translation,localization,and stability.Aberrant dynamic regulation of RNA N6-methyladenosine(m6 A)has been reported in numerous human diseases,including several cancers.In recent years,eukaryotic DNA N6-methyladenosine(6 mA)has also been reported and implicated in cancer progression and tumorigenesis.In this review,we summarize the contributions of N6-methyladenosine modification to cancer biology and pathogenesis in the context of both RNA and DNA.We also highlight the clinical relevance of targeting these modifications as a therapeutic strategy for cancer. 展开更多
关键词 N6-methyladenosine RNA methylation DNA methylation CANCER therapeutic targets
下载PDF
m^(6)A修饰调控细胞自噬参与雄性生殖疾病研究进展
14
作者 彭芃 戚星宇 +1 位作者 袁峥嵘 马毅 《生命科学研究》 CAS 2024年第1期41-47,70,共8页
N^(6)-甲基腺苷(N^(6)-methyladenosine, m^(6)A)修饰是在腺苷核苷酸N^(6)位置上发生的甲基化,在多种RNA代谢过程如m RNA剪接、翻译、运输、降解中发挥关键作用,进而对各种生命过程产生广泛影响。细胞自噬是真核细胞在自噬相关基因的调... N^(6)-甲基腺苷(N^(6)-methyladenosine, m^(6)A)修饰是在腺苷核苷酸N^(6)位置上发生的甲基化,在多种RNA代谢过程如m RNA剪接、翻译、运输、降解中发挥关键作用,进而对各种生命过程产生广泛影响。细胞自噬是真核细胞在自噬相关基因的调控下通过溶酶体对自身细胞质蛋白质和受损细胞器进行降解的过程。本文总结了m^(6)A修饰调控细胞自噬在雄性生殖疾病发生发展过程中的研究进展,旨在为今后m^(6)A修饰调节自噬水平在雄性生殖中的调控机理研究提供参考资料,为雄性生殖疾病的治疗策略提供新方向。 展开更多
关键词 N^(6)-甲基腺苷(m^(6)A)修饰 RNA修饰 细胞自噬 雄性生殖疾病 男性不育
下载PDF
Genome-wide map of N6-methyladenosine circular RNAs identified in mice model of severe acute pancreatitis 被引量:3
15
作者 Jun Wu Xiao-Hui Yuan +7 位作者 Wen Jiang Yi-Chen Lu Qi-Lin Huang Yi Yang Hua-Ji Qie Jiang-Tao Liu Hong-Yu Sun Li-Jun Tang 《World Journal of Gastroenterology》 SCIE CAS 2021年第43期7530-7545,共16页
BACKGROUND Severe acute pancreatitis(SAP)is a deadly inflammatory disease with complex pathogenesis and lack of effective therapeutic options.N6-methyladenosine(m6A)modification of circRNAs plays important roles in ph... BACKGROUND Severe acute pancreatitis(SAP)is a deadly inflammatory disease with complex pathogenesis and lack of effective therapeutic options.N6-methyladenosine(m6A)modification of circRNAs plays important roles in physiological and pathological processes.However,the roles of m6A circRNA in the pathological process of SAP remains unknown.AIM To identify transcriptome-wide map of m6A circRNAs and to determine their biological significance and potential mechanisms in SAP.METHODS The SAP in C57BL/6 mice was induced using 4%sodium taurocholate salt.The transcriptome-wide map of m6A circRNAs was identified by m6A-modified RNA immunoprecipitation sequencing.The biological significance of circRNAs with differentially expressed m6A peaks was evaluated through gene ontology and Kyoto Encyclopedia of Genes and Genomes analysis.The underlying mechanism of m6A circRNAs in SAP was analyzed by constructing of m6A circRNAmicroRNA networks.The expression of demethylases was determined by quantitative polymerase chain reaction and western blot to deduce the possible mechanism of reversible m6A process in SAP.RESULTS Fifty-seven circRNAs with differentially expressed m6A peaks were identified by m6A-modified RNA immunoprecipitation sequencing,of which 32 were upregulated and 25 downregulated.Functional analysis of these m6A circRNAs in SAP found some important pathways involved in the pathogenesis of SAP,such as regulation of autophagy and protein digestion.In m6A circRNA–miRNA networks,several important miRNAs participated in the occurrence and progression of SAP were found to bind to these m6A circRNAs,such as miR-24-3p,miR-26a,miR-92b,miR-216b,miR-324-5p and miR-762.Notably,the total m6A level of circRNAs was reduced,while the demethylase alkylation repair homolog 5 was upregulated in SAP.CONCLUSION m6A modification of circRNAs may be involved in the pathogenesis of SAP.Our findings may provide novel insights to explore the possible pathogenetic mechanism of SAP and seek new potential therapeutic targets for SAP. 展开更多
关键词 Severe acute pancreatitis Circular RNAs N6-methyladenosine MeRIP-seq Epigenetic analysis
下载PDF
N^(6)-甲基腺苷结合蛋白YTHDC2在肿瘤中的研究进展
16
作者 姜涛 李卫海 +1 位作者 何作顺 谷仕艳 《中国病理生理杂志》 CAS CSCD 北大核心 2023年第9期1697-1701,共5页
N^(6)-甲基腺苷(N^(6)-methyladenosine,m^(6)A)是真核生物RNA上最常见的可逆甲基化修饰,可影响相应RNA的加工和降解过程,进而调控细胞的生长、发育、分化和死亡等多种病理生理过程[1]。研究已明确,m^(6)A修饰是由甲基转移酶、去甲基转... N^(6)-甲基腺苷(N^(6)-methyladenosine,m^(6)A)是真核生物RNA上最常见的可逆甲基化修饰,可影响相应RNA的加工和降解过程,进而调控细胞的生长、发育、分化和死亡等多种病理生理过程[1]。研究已明确,m^(6)A修饰是由甲基转移酶、去甲基转移酶和甲基结合蛋白(又称“redear”)共同调控的可逆修饰,其中甲基结合蛋白是m^(6)A修饰发挥生物学功能最重要的介导者[2]。 展开更多
关键词 含YTH结构域蛋白2 N^(6)-甲基腺苷 肿瘤 生物学功能
下载PDF
化学干预N^(6)-甲基腺嘌呤修饰的研究进展
17
作者 郇歆宇 赖淦强 +1 位作者 黄悦 杨财广 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2023年第3期22-35,共14页
信使RNA(Messenger RNA,mRNA)上存在众多修饰,包括N^(6)-甲基腺嘌呤修饰(N^(6)-methyladenosine,m^(6)A)、N1-甲基腺嘌呤修饰(N1-methyladenosine,m^(1)A)及胞嘧啶甲基化(5-methylcytosine,m^(5)C)等.其中,m^(6)A是mRNA内部修饰碱基中... 信使RNA(Messenger RNA,mRNA)上存在众多修饰,包括N^(6)-甲基腺嘌呤修饰(N^(6)-methyladenosine,m^(6)A)、N1-甲基腺嘌呤修饰(N1-methyladenosine,m^(1)A)及胞嘧啶甲基化(5-methylcytosine,m^(5)C)等.其中,m^(6)A是mRNA内部修饰碱基中占比最高的一种,影响着mRNA的5′和3′端加工、在细胞中的定位、降解和翻译等过程,并在转录后调控基因表达水平,以此参与胞内的多种生理活动.本文综合评述了m^(6)A修饰的分子机制及其与多种疾病的关系,概述了m^(6)A鉴定技术的发展历程,重点讨论了m^(6)A化学干预的最新研究进展,以期让读者全面了解m^(6)A修饰,并为后续开发针对m^(6)A修饰的小分子药物提供参考. 展开更多
关键词 N^(6)-甲基腺嘌呤修饰 甲基转移酶 去甲基化酶 小分子抑制剂 小分子激动剂
下载PDF
N^(6)-腺苷酸甲基化修饰在心血管疾病中的研究 进展
18
作者 袁群凯 张群吉 +1 位作者 侯经远 钟志雄 《国际心血管病杂志》 2023年第6期337-340,349,共5页
N^(6)-腺苷酸甲基化(m6A)是真核生物mRNA最常见的转录后修饰,是一种动态可逆的过程。m6A受甲基化酶、去甲基化酶及甲基化阅读蛋白的调节,参与多种基因表达调控和疾病的病理过程。随着测序技术的发展,m6A在心血管疾病中的研究逐渐增多。... N^(6)-腺苷酸甲基化(m6A)是真核生物mRNA最常见的转录后修饰,是一种动态可逆的过程。m6A受甲基化酶、去甲基化酶及甲基化阅读蛋白的调节,参与多种基因表达调控和疾病的病理过程。随着测序技术的发展,m6A在心血管疾病中的研究逐渐增多。该文介绍m6A在心血管疾病中的相关研究,探讨其在心血管疾病发生中的作用及可能机制。 展开更多
关键词 心血管疾病 N^(6)-腺苷酸甲基化 转录后修饰
下载PDF
m^(6)A甲基化修饰在重度抑郁症中的作用
19
作者 曲智 段东晓 《生理科学进展》 CAS 北大核心 2024年第2期185-190,共6页
N^(6)-甲基腺苷(N^(6)-methyladenosine,m^(6)A)是真核生物RNA中常见且可逆的mRNA修饰,属于表观遗传学修饰之一。在甲基转移酶、去甲基化酶及阅读蛋白的调控下,m^(6)A修饰通过介导RNA转录、剪接、翻译等过程来影响相关蛋白质的表达,调... N^(6)-甲基腺苷(N^(6)-methyladenosine,m^(6)A)是真核生物RNA中常见且可逆的mRNA修饰,属于表观遗传学修饰之一。在甲基转移酶、去甲基化酶及阅读蛋白的调控下,m^(6)A修饰通过介导RNA转录、剪接、翻译等过程来影响相关蛋白质的表达,调控机体的生理生化过程。重度抑郁症(major depressive disorder,MDD)作为一种发病率高,治愈率低且极易复发的精神类疾病,其致病因素诸多,如遗传因素、环境因素和表观遗传学因素等,但其发病具体机制尚不清楚。近期研究发现m^(6)A修饰与MDD发病之间存在密切关系,并逐渐成为研究MDD发病机制的热点。本文通过对m^(6)A甲基化修饰过程及相关酶类在MDD患者中枢神经系统的表达及作用进行综述,以期为重度抑郁症的研究和治疗提供新的思路及药物靶点。 展开更多
关键词 N^(6)-甲基腺苷 重度抑郁症 甲基化 m^(6)A甲基转移酶 m^(6)A去甲基化酶
下载PDF
m^(6)A甲基化修饰在肿瘤耐药中的作用机制研究进展
20
作者 陈珊珊 伍燕 +1 位作者 颜新建 李高峰 《医学综述》 CAS 2024年第2期177-181,共5页
N^(6)-甲基腺嘌呤(m^(6)A)甲基化是哺乳动物体内最常见、规模最大的一类RNA修饰过程,属于表观遗传学修饰之一,在甲基化酶、去甲基化酶、识别酶等调控下参与RNA转录、核输出、翻译和微RNA的加工处理等,因此m^(6)A甲基化修饰可调控基因的... N^(6)-甲基腺嘌呤(m^(6)A)甲基化是哺乳动物体内最常见、规模最大的一类RNA修饰过程,属于表观遗传学修饰之一,在甲基化酶、去甲基化酶、识别酶等调控下参与RNA转录、核输出、翻译和微RNA的加工处理等,因此m^(6)A甲基化修饰可调控基因的表达。肿瘤耐药性是肿瘤临床治疗的主要障碍,在细胞癌变过程中,m^(6)A甲基化修饰可通过调控基因的表达、激活或抑制信号转导通路等引发相应信使RNA翻译改变,促进肿瘤进展,导致再次使用靶向药物时产生耐药性。因此,深入研究m^(6)A甲基化修饰在肿瘤耐药中的作用机制,可以为肿瘤的治疗提供新思路。 展开更多
关键词 肿瘤耐药 N^(6)-甲基腺嘌呤甲基化 甲基化酶 去甲基化酶 识别酶
下载PDF
上一页 1 2 11 下一页 到第
使用帮助 返回顶部